U.S. flag

An official website of the United States government

Display optionsSort by RelevanceDownload
Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 397

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)		Review status
1.
GRCh37:
Chr2:228149043
GRCh38:
Chr2:227284327
MFF-DT, COL4A3G955RAutosomal dominant Alport syndromeLikely pathogenic
(Feb 23, 2023)		criteria provided, single submitter
2.
GRCh37:
Chr2:228118876
GRCh38:
Chr2:227254160
COL4A3, MFF-DTP272SAutosomal recessive Alport syndrome, Autosomal dominant Alport syndromeUncertain significance
(Feb 28, 2023)		criteria provided, single submitter
3.
GRCh37:
Chr2:228148537
GRCh38:
Chr2:227283821
COL4A3, MFF-DTG904EAutosomal dominant Alport syndromeLikely pathogenic
(Jul 28, 2022)		criteria provided, single submitter
4.
GRCh37:
Chr2:228137720
GRCh38:
Chr2:227273004
COL4A3, MFF-DTG605VAutosomal dominant Alport syndromeLikely pathogenic
(Jul 29, 2022)		criteria provided, single submitter
5.
GRCh37:
Chr2:228110715
GRCh38:
Chr2:227245999
COL4A3, MFF-DTG124RAutosomal dominant Alport syndromeLikely pathogenic
(Mar 11, 2022)		criteria provided, single submitter
6.
GRCh37:
Chr2:228155463
GRCh38:
Chr2:227290747
COL4A3, MFF-DTG1024VAutosomal dominant Alport syndromeUncertain significance
(Jul 11, 2022)		criteria provided, single submitter
7.
GRCh37:
Chr2:228145262
GRCh38:
Chr2:227280546
COL4A3, MFF-DTG777DAutosomal dominant Alport syndromeLikely pathogenic
(Aug 3, 2022)		criteria provided, single submitter
8.
GRCh37:
Chr2:228121069
GRCh38:
Chr2:227256353
COL4A3, MFF-DTG315DAutosomal dominant Alport syndromeLikely pathogenic
(Jun 14, 2022)		no assertion criteria provided
9.
GRCh37:
Chr2:228158034
GRCh38:
Chr2:227293318
COL4A3, MFF-DTAutosomal dominant Alport syndromePathogenic
(May 4, 2022)		criteria provided, single submitter
10.
GRCh37:
Chr2:228004904
GRCh38:
Chr2:227140188
COL4A4C55*Autosomal dominant Alport syndromePathogenic
(May 4, 2022)		criteria provided, single submitter
11.
GRCh37:
Chr2:228131709
GRCh38:
Chr2:227266993
COL4A3, MFF-DTG470EAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal dominant Alport syndrome,
Autosomal recessive Alport syndrome, not provided		Conflicting interpretations of pathogenicity
(Apr 19, 2022)		criteria provided, conflicting interpretations
12.
GRCh37:
Chr2:228147240
GRCh38:
Chr2:227282524
COL4A3, MFF-DTG883EAutosomal dominant Alport syndromeUncertain significance
(Sep 3, 2021)		criteria provided, single submitter
13.
GRCh37:
Chr2:227872782-227872783
GRCh38:
Chr2:227008066-227008067
COL4A4C1588fsAutosomal dominant Alport syndromeLikely pathogenic
(Oct 1, 2021)		criteria provided, single submitter
14.
GRCh37:
Chr2:228112259
GRCh38:
Chr2:227247543
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Benign/Likely benign
(Mar 31, 2022)		criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr2:228157900
GRCh38:
Chr2:227293184
COL4A3, MFF-DTnot provided, Benign familial hematuria, Autosomal dominant Alport syndrome,
Autosomal recessive Alport syndrome		Likely benign
(Sep 18, 2022)		criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr2:228157894
GRCh38:
Chr2:227293178
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Sep 17, 2022)		criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr2:228128656
GRCh38:
Chr2:227263940
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Apr 8, 2022)		criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr2:228145591
GRCh38:
Chr2:227280875
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Apr 27, 2022)		criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr2:228122313
GRCh38:
Chr2:227257597
COL4A3, MFF-DTnot provided, Benign familial hematuria, Autosomal dominant Alport syndrome,
Autosomal recessive Alport syndrome		Likely benign
(Aug 3, 2022)		criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr2:228110650
GRCh38:
Chr2:227245934
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Jan 27, 2022)		criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr2:228119448
GRCh38:
Chr2:227254732
COL4A3, MFF-DTBenign familial hematuria, Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome,
not provided		Benign/Likely benign
(Sep 23, 2022)		criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr2:228158048
GRCh38:
Chr2:227293332
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely benign
(Jul 25, 2022)		criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr2:228125786
GRCh38:
Chr2:227261070
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely benign
(Mar 18, 2022)		criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr2:228142283
GRCh38:
Chr2:227277567
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely benign
(May 17, 2022)		criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr2:228115877
GRCh38:
Chr2:227251161
COL4A3, MFF-DTF190LAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Conflicting interpretations of pathogenicity
(Aug 16, 2022)		criteria provided, conflicting interpretations
26.
GRCh37:
Chr2:228145262
GRCh38:
Chr2:227280546
COL4A3, MFF-DTG777VAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Pathogenic/Likely pathogenic
(Jan 25, 2022)		criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr2:228135504
GRCh38:
Chr2:227270788
MFF-DT, COL4A3G532SAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely pathogenic
(Mar 12, 2022)		criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr2:228104949
GRCh38:
Chr2:227240233
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely pathogenic
(Mar 22, 2022)		criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr2:228124594
GRCh38:
Chr2:227259878
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely pathogenic
(Mar 29, 2022)		criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr2:228159724
GRCh38:
Chr2:227295008
COL4A3, MFF-DTG1155SAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely pathogenic
(Dec 26, 2021)		criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:228142177
GRCh38:
Chr2:227277461
COL4A3, MFF-DTS678YAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Dec 21, 2021)		criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr2:228154805
GRCh38:
Chr2:227290089
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided		Likely pathogenic
(Jan 17, 2022)		criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr2:228131208
GRCh38:
Chr2:227266492
COL4A3, MFF-DTG464EAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely pathogenic
(Sep 29, 2021)		criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr2:228168620
GRCh38:
Chr2:227303904
COL4A3, MFF-DTG1334Enot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome		Pathogenic
(Mar 1, 2023)		criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr2:228159725
GRCh38:
Chr2:227295009
COL4A3, MFF-DTG1155DAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Pathogenic
(Oct 2, 2021)		criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr2:228153898-228153899
GRCh38:
Chr2:227289182-227289183
COL4A3, MFF-DTG973fsAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Pathogenic
(Jul 15, 2022)		criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr2:228157929
GRCh38:
Chr2:227293213
COL4A3, MFF-DTD1078GAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(Aug 27, 2021)		criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr2:228128606
GRCh38:
Chr2:227263890
COL4A3, MFF-DTG421fsAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Pathogenic/Likely pathogenic
(Jul 18, 2022)		criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr2:228137832
GRCh38:
Chr2:227273116
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(Mar 10, 2022)		criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr2:228148566
GRCh38:
Chr2:227283850
COL4A3, MFF-DTQ914KAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Conflicting interpretations of pathogenicity
(Jun 27, 2022)		criteria provided, conflicting interpretations
41.
GRCh37:
Chr2:228142198
GRCh38:
Chr2:227277482
COL4A3, MFF-DTP685LAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(Nov 19, 2021)		criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr2:228159263
GRCh38:
Chr2:227294547
COL4A3, MFF-DTP1132HAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(Apr 19, 2022)		criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr2:228029467
GRCh38:
Chr2:227164751
COL4A3P9SAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Conflicting interpretations of pathogenicity
(Jul 6, 2022)		criteria provided, conflicting interpretations
44.
GRCh37:
Chr2:228162443
GRCh38:
Chr2:227297727
COL4A3, MFF-DTG1207RAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Pathogenic
(May 17, 2022)		criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:228137762
GRCh38:
Chr2:227273046
COL4A3, MFF-DTG619EAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(May 14, 2022)		criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr2:228118823
GRCh38:
Chr2:227254107
COL4A3, MFF-DTAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Conflicting interpretations of pathogenicity
(Aug 23, 2022)		criteria provided, conflicting interpretations
47.
GRCh37:
Chr2:228109061
GRCh38:
Chr2:227244345
COL4A3, MFF-DTT87MAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Conflicting interpretations of pathogenicity
(Aug 22, 2022)		criteria provided, conflicting interpretations
48.
GRCh37:
Chr2:228131189
GRCh38:
Chr2:227266473
COL4A3, MFF-DTG458RAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Pathogenic/Likely pathogenic
(Oct 4, 2021)		criteria provided, multiple submitters, no conflicts
49.
GRCh37:
ChrX:107834875
GRCh38:
ChrX:108591645
COL4A5not providedLikely pathogenic
(Dec 23, 2021)		criteria provided, single submitter
50.
GRCh37:
ChrX:107858141
GRCh38:
ChrX:108614911
COL4A5G799DAutosomal dominant Alport syndromeLikely pathogenic
(Feb 14, 2019)		no assertion criteria provided
51.
GRCh37:
Chr2:228144571
GRCh38:
Chr2:227279855
COL4A3, MFF-DTG730RAutosomal dominant Alport syndromeUncertain significance
(Feb 21, 2022)		criteria provided, single submitter
52.
GRCh37:
Chr2:228115902
GRCh38:
Chr2:227251186
COL4A3, MFF-DTG198VAutosomal dominant Alport syndromeUncertain significance
(Feb 21, 2022)		criteria provided, single submitter
53.
GRCh37:
Chr2:228173996
GRCh38:
Chr2:227309280
COL4A3, MFF-DTG1573SAutosomal dominant Alport syndromeUncertain significance
(Feb 21, 2022)		criteria provided, single submitter
54.
GRCh37:
Chr2:228122352
GRCh38:
Chr2:227257636
COL4A3, MFF-DTR341CAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal dominant Alport syndrome		Uncertain significance
(Feb 21, 2022)		criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr2:228111429
GRCh38:
Chr2:227246713
COL4A3, MFF-DTG139EAutosomal dominant Alport syndromeUncertain significance
(Feb 21, 2022)		criteria provided, single submitter
56.
GRCh37:
Chr2:228148537
GRCh38:
Chr2:227283821
COL4A3, MFF-DTG904VAutosomal dominant Alport syndromeUncertain significance
(Feb 21, 2022)		criteria provided, single submitter
57.
GRCh37:
Chr2:228162483
GRCh38:
Chr2:227297767
COL4A3, MFF-DTI1220RAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Feb 17, 2022)		criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr2:227875185-227875202
GRCh38:
Chr2:227010469-227010486
COL4A4Autosomal recessive Alport syndrome, Autosomal dominant Alport syndromeLikely pathogenic
(Aug 13, 2021)		criteria provided, single submitter
59.
GRCh37:
Chr2:228147176
GRCh38:
Chr2:227282460
COL4A3, MFF-DTG862RAutosomal dominant Alport syndromeLikely pathogenic
(Jan 3, 2022)		criteria provided, single submitter
60.
GRCh37:
Chr2:228119423
GRCh38:
Chr2:227254707
COL4A3, MFF-DTG294RAutosomal dominant Alport syndromeLikely pathogenic
(Aug 2, 2021)		criteria provided, single submitter
61.
GRCh37:
Chr2:228157923
GRCh38:
Chr2:227293207
COL4A3, MFF-DTP1076LAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Feb 5, 2022)		criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr2:228157948
GRCh38:
Chr2:227293232
COL4A3, MFF-DTE1084DAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Dec 30, 2021)		criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr2:228115896
GRCh38:
Chr2:227251180
COL4A3, MFF-DTP196LAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Nov 26, 2021)		criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr2:228141143
GRCh38:
Chr2:227276427
COL4A3, MFF-DTP657LAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Feb 9, 2022)		criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr2:228029453
GRCh38:
Chr2:227164737
COL4A3R4QAutosomal recessive Alport syndrome, Autosomal dominant Alport syndrome, Benign familial hematuria,
not provided		Uncertain significance
(Mar 17, 2023)		criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr2:228144518
GRCh38:
Chr2:227279802
MFF-DT, COL4A3G712VAutosomal dominant Alport syndromeLikely pathogenic
(Mar 25, 2021)		criteria provided, single submitter
67.
GRCh37:
Chr2:228159661
GRCh38:
Chr2:227294945
COL4A3, MFF-DTnot provided, Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome
Benign
(Jul 30, 2021)		criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr2:228147063
GRCh38:
Chr2:227282347
COL4A3, MFF-DTnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Benign/Likely benign
(Oct 26, 2022)		criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr2:228115892
GRCh38:
Chr2:227251176
MFF-DT, COL4A3G195SAutosomal dominant Alport syndromeAffects
(Jul 7, 2021)		no assertion criteria provided
70.
GRCh37:
Chr2:228155592
GRCh38:
Chr2:227290876
COL4A3, MFF-DTP1067LAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Uncertain significance
(Sep 16, 2021)		criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr2:228118277
GRCh38:
Chr2:227253561
MFF-DT, COL4A3G230Snot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Likely pathogenic
(Apr 14, 2022)		criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr2:228172559
GRCh38:
Chr2:227307843
COL4A3, MFF-DTAutosomal recessive Alport syndrome, Autosomal dominant Alport syndromeUncertain significance
(Jul 14, 2021)		criteria provided, single submitter
73.
GRCh37:
Chr2:228163401
GRCh38:
Chr2:227298685
COL4A3, MFF-DTA1252GAutosomal dominant Alport syndrome, Autosomal recessive Alport syndromeUncertain significance
(Jul 14, 2021)		criteria provided, single submitter
74.
GRCh37:
Chr2:228158019
GRCh38:
Chr2:227293303
COL4A3, MFF-DTS1108IAutosomal dominant Alport syndrome, Autosomal recessive Alport syndromeUncertain significance
(Jul 14, 2021)		criteria provided, single submitter
75.
GRCh37:
Chr2:228174032
GRCh38:
Chr2:227309316
MFF-DT, COL4A3M1585VAutosomal dominant Alport syndrome, Autosomal recessive Alport syndromeUncertain significance
(Jul 14, 2021)		criteria provided, single submitter
76.
GRCh37:
Chr2:228172488
GRCh38:
Chr2:227307772
COL4A3, MFF-DTA1439TAutosomal dominant Alport syndrome, Autosomal recessive Alport syndromeUncertain significance
(Jul 14, 2021)		criteria provided, single submitter
77.
GRCh37:
Chr2:228162415
GRCh38:
Chr2:227297699
COL4A3, MFF-DTAutosomal recessive Alport syndrome, not provided, Autosomal dominant Alport syndrome
Conflicting interpretations of pathogenicity
(Jul 14, 2021)		criteria provided, conflicting interpretations
78.
GRCh37:
Chr2:228174052
GRCh38:
Chr2:227309336
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Benign/Likely benign
(Aug 15, 2022)		criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr2:228159761
GRCh38:
Chr2:227295045
COL4A3, MFF-DTG1167EAutosomal dominant Alport syndromePathogenic
(Jul 15, 2021)		criteria provided, single submitter
80.
GRCh37:
Chr2:228162507
GRCh38:
Chr2:227297791
MFF-DT, COL4A3G1228VAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely pathogenic
(Oct 8, 2022)		criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr2:228142192
GRCh38:
Chr2:227277476
COL4A3, MFF-DTG683EAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Conflicting interpretations of pathogenicity
(Oct 10, 2021)		criteria provided, conflicting interpretations
82.
GRCh37:
Chr2:228118022
GRCh38:
Chr2:227253306
COL4A3, MFF-DTG219VAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome
Likely pathogenic
(Jul 29, 2021)		criteria provided, single submitter
83.
GRCh37:
Chr2:228147195
GRCh38:
Chr2:227282479
COL4A3, MFF-DTG868EAutosomal dominant Alport syndromePathogenic
(Jul 7, 2021)		no assertion criteria provided
84.
GRCh37:
Chr2:228147076
GRCh38:
Chr2:227282360
COL4A3, MFF-DTnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Likely benign
(Oct 20, 2022)		criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr2:228110729
GRCh38:
Chr2:227246013
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 8, 2021)		criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr2:228163462
GRCh38:
Chr2:227298746
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Sep 14, 2022)		criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr2:228137781
GRCh38:
Chr2:227273065
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 31, 2022)		criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr2:228159759
GRCh38:
Chr2:227295043
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Jan 1, 2022)		criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr2:228175587
GRCh38:
Chr2:227310871
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Jun 28, 2022)		criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr2:228142184
GRCh38:
Chr2:227277468
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 6, 2021)		criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr2:228163402
GRCh38:
Chr2:227298686
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 9, 2022)		criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr2:228172487
GRCh38:
Chr2:227307771
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Sep 23, 2022)		criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr2:228173730
GRCh38:
Chr2:227309014
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Apr 30, 2022)		criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr2:228148581
GRCh38:
Chr2:227283865
COL4A3, MFF-DTnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Likely benign
(May 21, 2022)		criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr2:228137766
GRCh38:
Chr2:227273050
COL4A3, MFF-DTnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Likely benign
(Sep 14, 2022)		criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr2:228112308
GRCh38:
Chr2:227247592
COL4A3, MFF-DTnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome		Likely benign
(Sep 13, 2022)		criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr2:228155524
GRCh38:
Chr2:227290808
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 4, 2022)		criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr2:228109656-228109657
GRCh38:
Chr2:227244940-227244941
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Aug 10, 2022)		criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr2:228147072
GRCh38:
Chr2:227282356
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Sep 8, 2022)		criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr2:228118821
GRCh38:
Chr2:227254105
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome,
not provided		Likely benign
(Oct 13, 2022)		criteria provided, multiple submitters, no conflicts
Display optionsSort by RelevanceDownload
Format
Items per page
Sort by
Choose Destination